MedPath

A study to test the effectiveness of Ushiradi yogam in Type 2 Diabetes mellitus

Phase 3
Not yet recruiting
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/11/059875
Lead Sponsor
Dr Geethu Gangadharan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. participants of both male and female in the age group of 25-75 years

2. participants with FBS level from 126mg/dl -250mg/dl or PPBS level from 200mg/dl-400mg/dl

3. participants with HbA1c level from 6.5%- 9.5%

4. participants taking stable dose of oral hypoglycemic agents.

Exclusion Criteria

1. participants with the history of severe cardiac, pulmonary, hepatic disorders or neoplasm

2.Pregnant or lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the blood parameters <br/ ><br> 1.FBS <br/ ><br> 2. PPBS <br/ ><br> 3.HbA1c <br/ ><br>Timepoint: Baseline, 4 weeks,8 weeks, 12 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
For Standardization of the study drug physical parameters like Ash value, extractive value, TLCTimepoint: 90th day
© Copyright 2025. All Rights Reserved by MedPath